ABSTRACT
Background It remains controversial whether daytime napping is beneficial for human health.
Objective To examine the causal relationship between daytime napping and the risk for various human diseases.
Design Phenotype-wide Mendelian randomization study.
Setting Non-UK Biobank cohorts reported in published genome-wide association studies (GWAS) provided the outcome phenotypes in the discovery stage. The UK Biobank cohort provided the outcome phenotypes in the validation stage.
Participants The UK Biobank GWAS included 361,194 European-ancestry residents in the UK. Non-UKBB GWAS included various numbers of participants.
Exposure Self-reported daytime napping frequency.
Main outcome measure A wide-spectrum of human health outcomes including obesity, major depressive disorder, and high cholesterol.
Methods We examined the causal relationship between daytime napping frequency in the UK Biobank as exposure and a panel of 1,146 health outcomes reported in genome-wide association studies (GWAS), using a two-sample Mendelian randomization analysis. The significant findings were further validated in the UK Biobank health outcomes of 4,203 human traits and diseases. The causal effects were estimated using a fixed-effect inverse variance weighted model. MR-Egger intercept test was applied to detect horizontal pleiotropy, along with Cochran’s Q test to assess heterogeneity among the causal effects of IVs.
Findings There were significant causal relationships between daytime napping frequency and a wide spectrum of human health outcomes. In particular, we validated that frequent daytime napping increased the risks of major depressive disorder, obesity and abnormal lipid profile.
Interpretation The current study showed that frequent daytime napping mainly had adverse impacts on physical and mental health. Cautions should be taken for health recommendations on daytime napping. Further studies are necessary to precisely define the best daytime napping strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the start-up of the Office of Vice President for Research of Wayne State University (W.L.). P. C. was supported by Changbai Mountain Scholars Program of Jilin Provence. All sources of funding were not involved in the study design, data collection and analysis, interpretation of the results, manuscript writing, or the decision in submitting the manuscript for publication. The authors are independent from these funding sources. The authors have full access to the GWAS summary statistics of UKBB, can take the responsibility for the integrity of these summary statistics and the accuracy of the data analysis that have been done by the authors.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Perl script and R code used in this study are available upon request from the corresponding author at pchen{at}jlu.edu.cn. The summary statistics of published GWAS are available from MRbase webapp (http://www.mrbase.org/) and can be accessed through TwoSampleMR package (https://github.com/MRCIEU/TwoSampleMR). UKBB GWAS summary statistics are available from Benjamin Neale’s website (http://www.nealelab.is/uk-biobank, GWAS round 2).
